| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
103,802 |
100,288 |
$15.06M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,556 |
46,324 |
$13.80M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
66,206 |
57,381 |
$5.62M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
25,488 |
24,484 |
$4.71M |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
71,427 |
63,177 |
$1.95M |
| 0225U |
|
4,256 |
3,802 |
$1.54M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
49,362 |
43,147 |
$1.41M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,691 |
3,474 |
$1.33M |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
570 |
340 |
$1.10M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,105 |
12,775 |
$1.09M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
40,881 |
36,092 |
$993K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
110,594 |
95,176 |
$956K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
962 |
928 |
$901K |
| 71046 |
Radiologic examination, chest; 2 views |
8,485 |
8,175 |
$729K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,392 |
11,608 |
$661K |
| G0378 |
Hospital observation service, per hour |
3,105 |
2,639 |
$584K |
| 80053 |
Comprehensive metabolic panel |
56,596 |
45,177 |
$554K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,772 |
11,265 |
$380K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,943 |
6,988 |
$370K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,088 |
10,604 |
$362K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
348 |
325 |
$301K |
| A0436 |
Rotary wing air mileage, per statute mile |
568 |
338 |
$261K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,788 |
1,651 |
$256K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,009 |
934 |
$233K |
| 36455 |
|
671 |
636 |
$213K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,323 |
1,249 |
$208K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,086 |
2,108 |
$156K |
| 86780 |
|
8,218 |
7,785 |
$153K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
219 |
210 |
$147K |
| 86703 |
|
8,516 |
8,086 |
$139K |
| 95782 |
|
163 |
162 |
$138K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,614 |
540 |
$137K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,014 |
2,917 |
$125K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,255 |
4,985 |
$115K |
| 87088 |
|
10,112 |
9,634 |
$112K |
| 82728 |
|
5,162 |
4,517 |
$96K |
| 81001 |
|
25,083 |
23,933 |
$94K |
| A0425 |
Ground mileage, per statute mile |
829 |
498 |
$94K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,547 |
2,474 |
$94K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
287 |
169 |
$92K |
| J3490 |
Unclassified drugs |
5,538 |
3,741 |
$91K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,967 |
10,903 |
$91K |
| 81025 |
|
10,898 |
10,389 |
$91K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
76 |
76 |
$90K |
| 86850 |
|
5,292 |
4,580 |
$83K |
| 99157 |
|
195 |
191 |
$82K |
| J9271 |
Injection, pembrolizumab, 1 mg |
65 |
50 |
$81K |
| 36430 |
|
173 |
102 |
$63K |
| 86922 |
|
427 |
397 |
$61K |
| 85045 |
|
11,038 |
9,935 |
$61K |
| 83020 |
|
3,176 |
3,014 |
$58K |
| 86762 |
|
2,748 |
2,609 |
$55K |
| 82570 |
|
6,778 |
6,293 |
$53K |
| 76770 |
|
311 |
310 |
$50K |
| 84439 |
|
3,956 |
3,845 |
$49K |
| 87631 |
|
563 |
548 |
$48K |
| 86787 |
|
2,613 |
2,484 |
$46K |
| 62323 |
|
252 |
250 |
$46K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
517 |
161 |
$44K |
| 87641 |
|
1,834 |
1,764 |
$44K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
630 |
590 |
$44K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
362 |
218 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
18,237 |
15,392 |
$43K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
171 |
153 |
$43K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
612 |
445 |
$42K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
592 |
515 |
$39K |
| 88142 |
|
1,373 |
1,291 |
$38K |
| 80061 |
Lipid panel |
2,201 |
2,078 |
$37K |
| 86923 |
|
326 |
278 |
$37K |
| 36591 |
|
2,290 |
1,363 |
$36K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
41 |
38 |
$36K |
| 86803 |
|
1,642 |
1,540 |
$35K |
| 87340 |
|
2,805 |
2,667 |
$35K |
| 80069 |
|
3,282 |
3,031 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,171 |
1,035 |
$35K |
| 81003 |
|
11,562 |
10,982 |
$33K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
707 |
579 |
$32K |
| 84156 |
|
6,068 |
5,496 |
$30K |
| 86902 |
|
986 |
918 |
$30K |
| 83735 |
|
6,007 |
4,848 |
$30K |
| 82962 |
|
7,901 |
7,397 |
$30K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
114 |
75 |
$30K |
| 87081 |
|
3,659 |
3,526 |
$27K |
| 84484 |
|
2,277 |
1,931 |
$26K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
84 |
76 |
$24K |
| 86900 |
|
5,977 |
5,163 |
$24K |
| 71250 |
|
134 |
128 |
$24K |
| 86901 |
|
5,977 |
5,163 |
$24K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
317 |
222 |
$24K |
| 83021 |
|
979 |
924 |
$23K |
| 82784 |
|
727 |
720 |
$23K |
| 83615 |
|
2,836 |
2,600 |
$23K |
| 70450 |
Computed tomography, head or brain; without contrast material |
57 |
49 |
$22K |
| 82951 |
|
1,118 |
1,014 |
$21K |
| 83690 |
|
2,417 |
2,263 |
$21K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
24 |
24 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,473 |
1,443 |
$20K |
| 96376 |
|
215 |
82 |
$18K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
80 |
60 |
$18K |
| 85027 |
|
1,996 |
1,645 |
$18K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,762 |
1,304 |
$17K |
| 87150 |
|
404 |
391 |
$17K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
54 |
51 |
$17K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
147 |
108 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,084 |
1,006 |
$14K |
| J0475 |
Injection, baclofen, 10 mg |
40 |
36 |
$14K |
| 82610 |
|
558 |
544 |
$12K |
| 84466 |
|
666 |
592 |
$12K |
| 86160 |
|
429 |
423 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,529 |
1,344 |
$11K |
| 86141 |
|
651 |
636 |
$11K |
| 83540 |
|
1,170 |
1,081 |
$11K |
| 84100 |
|
4,099 |
3,216 |
$10K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
27 |
27 |
$10K |
| 74240 |
|
25 |
25 |
$10K |
| 82607 |
|
432 |
415 |
$10K |
| 86162 |
|
411 |
405 |
$10K |
| 85660 |
|
983 |
915 |
$9K |
| 87430 |
|
642 |
635 |
$9K |
| 82950 |
|
1,455 |
1,423 |
$9K |
| 99155 |
|
59 |
55 |
$8K |
| 92567 |
|
337 |
324 |
$8K |
| 83970 |
|
242 |
229 |
$8K |
| 92588 |
|
54 |
54 |
$8K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
27 |
26 |
$7K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
746 |
627 |
$7K |
| 84300 |
|
1,120 |
1,107 |
$7K |
| 74018 |
|
65 |
64 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,191 |
1,107 |
$7K |
| 93886 |
|
27 |
25 |
$6K |
| 87077 |
|
571 |
543 |
$6K |
| 84133 |
|
1,100 |
1,088 |
$6K |
| 87070 |
|
532 |
523 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
87 |
83 |
$6K |
| 83880 |
|
134 |
118 |
$6K |
| 84702 |
|
476 |
427 |
$6K |
| 80197 |
|
2,502 |
1,850 |
$6K |
| 85007 |
|
1,244 |
938 |
$6K |
| 84703 |
|
484 |
451 |
$5K |
| 82550 |
|
725 |
718 |
$5K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
160 |
154 |
$5K |
| 82565 |
|
767 |
738 |
$5K |
| 86832 |
|
172 |
165 |
$4K |
| 80051 |
|
587 |
570 |
$4K |
| 83002 |
|
152 |
148 |
$4K |
| 87799 |
|
1,096 |
954 |
$4K |
| 86833 |
|
172 |
165 |
$4K |
| 83001 |
|
139 |
135 |
$4K |
| 76937 |
|
73 |
70 |
$3K |
| 87497 |
|
758 |
678 |
$3K |
| 92579 |
|
59 |
57 |
$3K |
| 82657 |
|
71 |
68 |
$3K |
| J3535 |
Drug administered through a metered dose inhaler |
67 |
66 |
$3K |
| 84403 |
|
71 |
71 |
$3K |
| 82043 |
|
378 |
372 |
$3K |
| 84425 |
|
90 |
80 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
205 |
201 |
$3K |
| 85652 |
|
802 |
787 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
39 |
38 |
$2K |
| 86592 |
|
466 |
457 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12 |
12 |
$2K |
| 0352U |
|
81 |
78 |
$2K |
| 84305 |
|
117 |
117 |
$2K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
339 |
300 |
$2K |
| 82670 |
|
53 |
50 |
$2K |
| 82088 |
|
35 |
35 |
$2K |
| 82746 |
|
84 |
74 |
$2K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
34 |
31 |
$2K |
| 88342 |
|
13 |
13 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
181 |
165 |
$2K |
| 87205 |
|
277 |
256 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
56 |
52 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
54 |
52 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
410 |
371 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
26 |
26 |
$1K |
| 84550 |
|
872 |
860 |
$1K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
42 |
42 |
$1K |
| 82040 |
|
169 |
153 |
$1K |
| 82157 |
|
26 |
26 |
$1K |
| 82105 |
|
66 |
66 |
$1K |
| 87210 |
|
233 |
214 |
$1K |
| 96417 |
|
17 |
12 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
31 |
15 |
$1K |
| 82677 |
|
42 |
42 |
$1K |
| A4217 |
Sterile water/saline, 500 ml |
241 |
221 |
$1K |
| 82627 |
|
28 |
28 |
$1K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
13 |
12 |
$1K |
| 83655 |
|
68 |
65 |
$1K |
| 84244 |
|
32 |
32 |
$876.80 |
| 97161 |
|
12 |
12 |
$876.03 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
32 |
12 |
$872.23 |
| 64642 |
|
14 |
14 |
$858.70 |
| 64644 |
|
16 |
12 |
$850.80 |
| 86336 |
|
42 |
42 |
$838.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
15 |
12 |
$746.29 |
| 85018 |
|
260 |
245 |
$731.32 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
202 |
182 |
$699.10 |
| 85014 |
|
261 |
241 |
$693.38 |
| 86769 |
|
42 |
41 |
$678.37 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
16 |
12 |
$653.28 |
| 82340 |
|
84 |
82 |
$538.67 |
| 87496 |
|
174 |
136 |
$530.04 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
116 |
97 |
$481.07 |
| Q3014 |
Telehealth originating site facility fee |
100 |
80 |
$468.80 |
| 80177 |
|
30 |
26 |
$457.38 |
| 83520 |
|
27 |
27 |
$446.85 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$426.10 |
| 76377 |
|
64 |
64 |
$385.65 |
| 84153 |
|
26 |
24 |
$335.50 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
44 |
39 |
$308.56 |
| G0239 |
Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) |
73 |
13 |
$292.66 |
| 84075 |
|
196 |
173 |
$284.37 |
| 82310 |
|
158 |
142 |
$271.30 |
| 84481 |
|
12 |
12 |
$262.39 |
| 87040 |
|
13 |
13 |
$249.38 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
52 |
42 |
$236.28 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
75 |
74 |
$233.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$191.52 |
| 80500 |
|
13 |
12 |
$178.80 |
| 83605 |
|
13 |
12 |
$178.24 |
| 87522 |
Neg quan hep c or qual rna |
18 |
15 |
$170.44 |
| 82378 |
|
17 |
12 |
$165.48 |
| 84165 |
|
27 |
26 |
$163.00 |
| 85730 |
|
42 |
38 |
$142.12 |
| 84520 |
|
771 |
740 |
$126.90 |
| 82947 |
|
606 |
586 |
$115.38 |
| 84155 |
|
187 |
169 |
$108.07 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
25 |
24 |
$100.96 |
| 87186 |
|
13 |
12 |
$97.57 |
| 82248 |
|
13 |
13 |
$96.73 |
| 85610 |
|
61 |
51 |
$94.46 |
| 83521 |
|
27 |
26 |
$82.82 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
766 |
588 |
$56.55 |
| 84436 |
|
41 |
39 |
$49.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$43.42 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
15 |
14 |
$22.25 |
| C1769 |
Guide wire |
13 |
12 |
$15.77 |
| 84132 |
|
13 |
12 |
$5.72 |
| 0100U |
|
49 |
45 |
$0.00 |